The role of surface immunoglobulin (Ig) in triggering B-lymphocyte responses is not yet clear. For several years it has been known that anti-Ig antibodies can interfere with the activation of B cells by mitogens (1)(2)(3)(4)(5). Whether this block is external, interfering with the mitogenic receptor, or internal, affecting deeper features of the cells' metabolism, is not yet established.Anti-Ig antibodies have a particularly deleterious effect on the immature B lymphocyte (6), suggesting that surface Ig may control the state of differentiation and activation of the B cell. First, immature B cells do not re-express their surface Ig molecules after capping and clearance with anti-Ig antibodies even though they do so after the removal of surface Ig from the membrane by enzymes (7). Second, after interaction with anti-Ig antibodies, immature B cells can no longer respond mitogenically to lipopolysaccharide (LPS) ~ (7). If surface Ig molecules are required for the action of mitogens, the immature B cells' lack of surface Ig re-expression could explain their insensitivity to LPS after anti-Ig treatment. Alternatively, anti-Ig treatment could have changed the activation potential of the immature B cells in some other way.The present studies were undertaken in hopes of elucidating the nature and mechanism of the anti-Ig-induced blockage of mitogen responsiveness. We have designed experiments to examine the action of LPS on adult mouse B cells in the few hours after exposure to anti-Ig antibodies when surface Ig has been capped and cleared but before new surface Ig is expressed (8). This paper reports that rather than merely being the initial target of mitogen action, surface Ig molecules in cooperation with Fc receptors are fundamentally involved in controlling the internal state of activation of the B lymphocyte.
Materials and MethodsCells. Adult (6-wk to 6-mo old) male and female C57BL/6 mice were used, either raised in our own facilities or purchased from The Jackson Laboratories, Bar Harbor, Maine. Their spleens were removed and teased into the standard medium of Hanks' balanced salt solution (BSS) (Microbiological Associates, Inc., Bethesda, Md.) plus 1% N-2-hydroxyethylpiperazone-N-2-ethane sulfonic acid (HEPES) (Microbiological Associates) plus 5% fetal calf serum (FCS) (Associl Abbreviations used in this paper: ALG, rabbit anti-mouse lymphocyte antibodies; BSS, balanced salt solution; FCS, fetal calf serum; FITC, fluorescein isothiocyanate; GAMG, goat antimouse Ig; GARG, goat anti-rabbit Ig; HGG, human IgG; LPS, lipopolysaccharide; NWSM, nocardia water-soluble mitogen; PPD, purified protein derivative; RAMG, rabbit anti-mouse Ig; RGG, rabbit IgG.